Global Small Interfering RNA (siRNA) Therapeutics Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Small Interfering RNA (siRNA) Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Small Interfering RNA (siRNA) Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Small Interfering RNA (siRNA) Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Small Interfering RNA (siRNA) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Small Interfering RNA (siRNA) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Small Interfering RNA (siRNA) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Small Interfering RNA (siRNA) Therapeutics players cover GE, Horizon Discovery, Thermo Scientific, and OPKO Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Interfering RNA (siRNA) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Small Interfering RNA (siRNA) Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Small Interfering RNA (siRNA) Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Small Interfering RNA (siRNA) Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Small Interfering RNA (siRNA) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Small Interfering RNA (siRNA) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Small Interfering RNA (siRNA) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Small Interfering RNA (siRNA) Therapeutics players cover GE, Horizon Discovery, Thermo Scientific, and OPKO Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Interfering RNA (siRNA) Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Liposome Based Systemic Therapy
- Nanoparticle Based Systemic Therapy
- Other
- Hospital
- Research Institutions
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE
- Horizon Discovery
- Thermo Scientific
- OPKO Health
- AInylam Pharmaceuticals
- Arrowhead Research
- Sanofi Genzyme
- Genecon Biotechnologies
- Arbutus Biopharma
- Silent Therapeutics
- Sylentis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2028
2.1.2 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Small Interfering RNA (siRNA) Therapeutics Segment by Type
2.2.1 Liposome Based Systemic Therapy
2.2.2 Nanoparticle Based Systemic Therapy
2.2.3 Other
2.3 Small Interfering RNA (siRNA) Therapeutics Market Size by Type
2.3.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Small Interfering RNA (siRNA) Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Small Interfering RNA (siRNA) Therapeutics Market Size by Application
2.5.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
3 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Players
3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS BY REGIONS
4.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
4.3 APAC Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
4.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2017-2022)
5.2 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
5.3 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2022)
6.2 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
6.3 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Therapeutics by Country (2017-2022)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET FORECAST
10.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast
10.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.2.2 Canada Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.2.3 Mexico Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.2.4 Brazil Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2023-2028)
10.3.1 China Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.2 Japan Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.3 Korea Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.5 India Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.6 Australia Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.2 France Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.3 UK Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.4 Italy Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.5 Russia Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.2 South Africa Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.3 Israel Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.4 Turkey Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.5 GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.6 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Type (2023-2028)
10.7 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 GE
11.1.1 GE Company Information
11.1.2 GE Small Interfering RNA (siRNA) Therapeutics Product Offered
11.1.3 GE Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GE Main Business Overview
11.1.5 GE Latest Developments
11.2 Horizon Discovery
11.2.1 Horizon Discovery Company Information
11.2.2 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
11.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Horizon Discovery Main Business Overview
11.2.5 Horizon Discovery Latest Developments
11.3 Thermo Scientific
11.3.1 Thermo Scientific Company Information
11.3.2 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
11.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Thermo Scientific Main Business Overview
11.3.5 Thermo Scientific Latest Developments
11.4 OPKO Health
11.4.1 OPKO Health Company Information
11.4.2 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
11.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 OPKO Health Main Business Overview
11.4.5 OPKO Health Latest Developments
11.5 AInylam Pharmaceuticals
11.5.1 AInylam Pharmaceuticals Company Information
11.5.2 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
11.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AInylam Pharmaceuticals Main Business Overview
11.5.5 AInylam Pharmaceuticals Latest Developments
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Information
11.6.2 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
11.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Arrowhead Research Main Business Overview
11.6.5 Arrowhead Research Latest Developments
11.7 Sanofi Genzyme
11.7.1 Sanofi Genzyme Company Information
11.7.2 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
11.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sanofi Genzyme Main Business Overview
11.7.5 Sanofi Genzyme Latest Developments
11.8 Genecon Biotechnologies
11.8.1 Genecon Biotechnologies Company Information
11.8.2 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
11.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Genecon Biotechnologies Main Business Overview
11.8.5 Genecon Biotechnologies Latest Developments
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Information
11.9.2 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
11.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Arbutus Biopharma Main Business Overview
11.9.5 Arbutus Biopharma Latest Developments
11.10 Silent Therapeutics
11.10.1 Silent Therapeutics Company Information
11.10.2 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
11.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Silent Therapeutics Main Business Overview
11.10.5 Silent Therapeutics Latest Developments
11.11 Sylentis
11.11.1 Sylentis Company Information
11.11.2 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
11.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sylentis Main Business Overview
11.11.5 Sylentis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2028
2.1.2 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Small Interfering RNA (siRNA) Therapeutics Segment by Type
2.2.1 Liposome Based Systemic Therapy
2.2.2 Nanoparticle Based Systemic Therapy
2.2.3 Other
2.3 Small Interfering RNA (siRNA) Therapeutics Market Size by Type
2.3.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Small Interfering RNA (siRNA) Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Academic Institutions
2.4.5 Other
2.5 Small Interfering RNA (siRNA) Therapeutics Market Size by Application
2.5.1 Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
3 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Players
3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) THERAPEUTICS BY REGIONS
4.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
4.3 APAC Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
4.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2017-2022)
5.2 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
5.3 Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2022)
6.2 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
6.3 APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Therapeutics by Country (2017-2022)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL INTERFERING RNA (SIRNA) THERAPEUTICS MARKET FORECAST
10.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast
10.1.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast
10.2 Americas Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.2.2 Canada Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.2.3 Mexico Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.2.4 Brazil Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3 APAC Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2023-2028)
10.3.1 China Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.2 Japan Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.3 Korea Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.5 India Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.3.6 Australia Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4 Europe Small Interfering RNA (siRNA) Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.2 France Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.3 UK Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.4 Italy Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.4.5 Russia Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.2 South Africa Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.3 Israel Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.4 Turkey Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.5.5 GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Forecast
10.6 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Type (2023-2028)
10.7 Global Small Interfering RNA (siRNA) Therapeutics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 GE
11.1.1 GE Company Information
11.1.2 GE Small Interfering RNA (siRNA) Therapeutics Product Offered
11.1.3 GE Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GE Main Business Overview
11.1.5 GE Latest Developments
11.2 Horizon Discovery
11.2.1 Horizon Discovery Company Information
11.2.2 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
11.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Horizon Discovery Main Business Overview
11.2.5 Horizon Discovery Latest Developments
11.3 Thermo Scientific
11.3.1 Thermo Scientific Company Information
11.3.2 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
11.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Thermo Scientific Main Business Overview
11.3.5 Thermo Scientific Latest Developments
11.4 OPKO Health
11.4.1 OPKO Health Company Information
11.4.2 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
11.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 OPKO Health Main Business Overview
11.4.5 OPKO Health Latest Developments
11.5 AInylam Pharmaceuticals
11.5.1 AInylam Pharmaceuticals Company Information
11.5.2 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
11.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AInylam Pharmaceuticals Main Business Overview
11.5.5 AInylam Pharmaceuticals Latest Developments
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Information
11.6.2 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
11.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Arrowhead Research Main Business Overview
11.6.5 Arrowhead Research Latest Developments
11.7 Sanofi Genzyme
11.7.1 Sanofi Genzyme Company Information
11.7.2 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
11.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sanofi Genzyme Main Business Overview
11.7.5 Sanofi Genzyme Latest Developments
11.8 Genecon Biotechnologies
11.8.1 Genecon Biotechnologies Company Information
11.8.2 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
11.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Genecon Biotechnologies Main Business Overview
11.8.5 Genecon Biotechnologies Latest Developments
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Information
11.9.2 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
11.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Arbutus Biopharma Main Business Overview
11.9.5 Arbutus Biopharma Latest Developments
11.10 Silent Therapeutics
11.10.1 Silent Therapeutics Company Information
11.10.2 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
11.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Silent Therapeutics Main Business Overview
11.10.5 Silent Therapeutics Latest Developments
11.11 Sylentis
11.11.1 Sylentis Company Information
11.11.2 Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
11.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sylentis Main Business Overview
11.11.5 Sylentis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Liposome Based Systemic Therapy
Table 3. Major Players of Nanoparticle Based Systemic Therapy
Table 4. Major Players of Other
Table 5. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
Table 14. Small Interfering RNA (siRNA) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Small Interfering RNA (siRNA) Therapeutics
Table 44. Key Market Challenges & Risks of Small Interfering RNA (siRNA) Therapeutics
Table 45. Key Industry Trends of Small Interfering RNA (siRNA) Therapeutics
Table 46. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. GE Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 53. GE Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 54. GE Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. GE Main Business
Table 56. GE Latest Developments
Table 57. Horizon Discovery Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 58. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 59. Horizon Discovery Main Business
Table 60. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Horizon Discovery Latest Developments
Table 62. Thermo Scientific Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 63. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 64. Thermo Scientific Main Business
Table 65. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Thermo Scientific Latest Developments
Table 67. OPKO Health Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 68. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 69. OPKO Health Main Business
Table 70. OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. OPKO Health Latest Developments
Table 72. AInylam Pharmaceuticals Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 73. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 74. AInylam Pharmaceuticals Main Business
Table 75. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. AInylam Pharmaceuticals Latest Developments
Table 77. Arrowhead Research Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 78. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 79. Arrowhead Research Main Business
Table 80. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Arrowhead Research Latest Developments
Table 82. Sanofi Genzyme Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 83. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 84. Sanofi Genzyme Main Business
Table 85. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sanofi Genzyme Latest Developments
Table 87. Genecon Biotechnologies Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 88. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 89. Genecon Biotechnologies Main Business
Table 90. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Genecon Biotechnologies Latest Developments
Table 92. Arbutus Biopharma Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 93. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 94. Arbutus Biopharma Main Business
Table 95. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Arbutus Biopharma Latest Developments
Table 97. Silent Therapeutics Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 98. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 99. Silent Therapeutics Main Business
Table 100. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Silent Therapeutics Latest Developments
Table 102. Sylentis Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 103. Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 104. Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Sylentis Main Business
Table 106. Sylentis Latest Developments
Table 1. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Liposome Based Systemic Therapy
Table 3. Major Players of Nanoparticle Based Systemic Therapy
Table 4. Major Players of Other
Table 5. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Small Interfering RNA (siRNA) Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Products Offered
Table 14. Small Interfering RNA (siRNA) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Small Interfering RNA (siRNA) Therapeutics
Table 44. Key Market Challenges & Risks of Small Interfering RNA (siRNA) Therapeutics
Table 45. Key Industry Trends of Small Interfering RNA (siRNA) Therapeutics
Table 46. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. GE Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 53. GE Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 54. GE Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. GE Main Business
Table 56. GE Latest Developments
Table 57. Horizon Discovery Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 58. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 59. Horizon Discovery Main Business
Table 60. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Horizon Discovery Latest Developments
Table 62. Thermo Scientific Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 63. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 64. Thermo Scientific Main Business
Table 65. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Thermo Scientific Latest Developments
Table 67. OPKO Health Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 68. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 69. OPKO Health Main Business
Table 70. OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. OPKO Health Latest Developments
Table 72. AInylam Pharmaceuticals Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 73. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 74. AInylam Pharmaceuticals Main Business
Table 75. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. AInylam Pharmaceuticals Latest Developments
Table 77. Arrowhead Research Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 78. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 79. Arrowhead Research Main Business
Table 80. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Arrowhead Research Latest Developments
Table 82. Sanofi Genzyme Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 83. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 84. Sanofi Genzyme Main Business
Table 85. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sanofi Genzyme Latest Developments
Table 87. Genecon Biotechnologies Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 88. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 89. Genecon Biotechnologies Main Business
Table 90. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Genecon Biotechnologies Latest Developments
Table 92. Arbutus Biopharma Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 93. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 94. Arbutus Biopharma Main Business
Table 95. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Arbutus Biopharma Latest Developments
Table 97. Silent Therapeutics Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 98. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 99. Silent Therapeutics Main Business
Table 100. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Silent Therapeutics Latest Developments
Table 102. Sylentis Details, Company Type, Small Interfering RNA (siRNA) Therapeutics Area Served and Its Competitors
Table 103. Sylentis Small Interfering RNA (siRNA) Therapeutics Product Offered
Table 104. Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Sylentis Main Business
Table 106. Sylentis Latest Developments
LIST OF FIGURES
Figure 1. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2021
Figure 7. Small Interfering RNA (siRNA) Therapeutics in Hospital
Figure 8. Global Small Interfering RNA (siRNA) Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Small Interfering RNA (siRNA) Therapeutics in Research Institutions
Figure 10. Global Small Interfering RNA (siRNA) Therapeutics Market: Research Institutions (2017-2022) & ($ Millions)
Figure 11. Small Interfering RNA (siRNA) Therapeutics in Pharmaceutical and Biotechnology Companies
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Market: Pharmaceutical and Biotechnology Companies (2017-2022) & ($ Millions)
Figure 13. Small Interfering RNA (siRNA) Therapeutics in Academic Institutions
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Market: Academic Institutions (2017-2022) & ($ Millions)
Figure 15. Small Interfering RNA (siRNA) Therapeutics in Other
Figure 16. Global Small Interfering RNA (siRNA) Therapeutics Market: Other (2017-2022) & ($ Millions)
Figure 17. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 18. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player in 2021
Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Small Interfering RNA (siRNA) Therapeutics Value Market Share by Country in 2021
Figure 25. Americas Small Interfering RNA (siRNA) Therapeutics Consumption Market Share by Type in 2021
Figure 26. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 27. United States Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2021
Figure 32. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 33. China Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2021
Figure 40. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2021
Figure 41. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 42. Germany Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 50. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. United States Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. China Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. India Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. France Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. UK Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 1. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2021
Figure 7. Small Interfering RNA (siRNA) Therapeutics in Hospital
Figure 8. Global Small Interfering RNA (siRNA) Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Small Interfering RNA (siRNA) Therapeutics in Research Institutions
Figure 10. Global Small Interfering RNA (siRNA) Therapeutics Market: Research Institutions (2017-2022) & ($ Millions)
Figure 11. Small Interfering RNA (siRNA) Therapeutics in Pharmaceutical and Biotechnology Companies
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Market: Pharmaceutical and Biotechnology Companies (2017-2022) & ($ Millions)
Figure 13. Small Interfering RNA (siRNA) Therapeutics in Academic Institutions
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Market: Academic Institutions (2017-2022) & ($ Millions)
Figure 15. Small Interfering RNA (siRNA) Therapeutics in Other
Figure 16. Global Small Interfering RNA (siRNA) Therapeutics Market: Other (2017-2022) & ($ Millions)
Figure 17. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 18. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Player in 2021
Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Small Interfering RNA (siRNA) Therapeutics Value Market Share by Country in 2021
Figure 25. Americas Small Interfering RNA (siRNA) Therapeutics Consumption Market Share by Type in 2021
Figure 26. Americas Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 27. United States Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2021
Figure 32. APAC Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 33. China Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Country in 2021
Figure 40. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2021
Figure 41. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 42. Germany Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Market Share by Application in 2021
Figure 50. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Small Interfering RNA (siRNA) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. United States Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. China Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. India Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. France Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. UK Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Size 2023-2028 ($ Millions)
